Finance

Lists
Why is 1779 up 2.76%?
Dive Deeper
1779:HKG
LongBio Pharma (Suzhou) Co Ltd
HK$74.40
+2.76%
(+2.00) 1D
Oct 16, 4:08:14 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1779...
Open
HK$73.25
High
HK$110.70
Low
HK$72.10
Mkt. cap
5.68B
Avg. vol.
198.51K
Volume
925.45K
52-wk high
HK$165.90
52-wk low
HK$71.90
EPS
-HK$3.42
Shares outstanding
75.06M
No. of employees
94
Open
HK$73.25
High
HK$110.70
Low
HK$72.10
Mkt. cap
5.68B
Avg. vol.
198.51K
Volume
925.45K
52-wk high
HK$165.90
52-wk low
HK$71.90
EPS
-HK$3.42
Shares outstanding
75.06M
No. of employees
94
News stories
From web sources and news partners
About LongBio Pharma (Suzhou) Co Ltd
CEO-
Employees94
Founded2020
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Jun 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
33.65M
30.26M
54.11M
54.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.67M
9.62M
12.40M
12.40M
Operating expense
39.40M
40.94M
66.89M
66.89M
Total operating expenses
39.40M
40.94M
66.89M
66.89M
Operating income
-39.40M
-40.94M
-66.89M
-66.89M
Other non operating income
6.50K
-
12.50K
12.50K
EBT including unusual items
-47.10M
-38.01M
-67.40M
-67.40M
EBT excluding unusual items
-47.37M
-41.15M
-67.86M
-67.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
76.50K
1.07M
376.50K
376.50K
Net income
-47.10M
-38.01M
-67.40M
-67.40M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
167.00K
49.00K
1.23M
1.23M
Interest expense
-8.14M
-252.00K
-322.00K
-322.00K
Net interest expenses
-7.97M
-203.00K
910.00K
910.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-38.47M
-40.00M
-65.82M
-65.82M
Gain or loss from assets sale
27.00K
-
1.50K
1.50K
AI content may include mistakes. Learn more
Google apps